Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation
July 22, 2019 16:15 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO) (the “Company,” “we” or “our”) today announced that it has commenced an offer to exchange (“Offer to...
Organogenesis Announces 2019 Sponsorship of American Podiatric Medical Association Educational Programs and Annual Scientific Meeting
July 08, 2019 08:00 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., July 08, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
July 01, 2019 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2019 Financial Results on August 9, 2019
June 06, 2019 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
May 10, 2019 07:08 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Receives Innovative Technology Contract from Vizient
May 01, 2019 08:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Latest Wound Care Research from Organogenesis Highlighted at SAWC Spring 2019
April 30, 2019 08:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass. and SAN ANTONIO, April 30, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and...
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2019 Financial Results on May 10, 2019
April 02, 2019 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Compliant With Nasdaq Listing Criteria
April 01, 2019 08:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and...
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results
March 18, 2019 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass. , March 18, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...